METASell
Meta Platforms
Price (1y)
Fair price check
6 different valuation methods each estimate what META should be worth, then we compare to today's price.
- EV/EBITDAUndervaluedthinks it's a bargain — estimates $742.04, about 21% above today
- P/E multiplesOvervaluedthinks it's expensive — estimates $523.41, about 15% below today
- P/B multiplesOvervaluedthinks it's expensive — estimates $222.12, about 64% below today
- DCF (2-stage)Overvaluedthinks it's expensive — estimates $207.29, about 66% below today
- Graham (defensive)Overvaluedthinks it's expensive — estimates $197.92, about 68% below today
- Residual IncomeOvervaluedthinks it's expensive — estimates $187.41, about 69% below today
How to read this: “Cheap” = method's fair price is at least 20% above today. “Fair” = within ±10–20%. “Pricey” = at least 10% below today. Outliers (values more than 5× or less than 0.2× today's price) are excluded.
Fair price ensemble
| Method | Value |
|---|---|
| Graham (defensive) | $197.92 |
| P/E multiples(vs sector peers) | $523.41 |
| P/B multiples(vs sector peers) | $222.12 |
| EV/EBITDA(vs sector peers) | $742.04 |
| Residual Income | $187.41 |
| DCF (2-stage) | $207.29 |
Median of all applicable methods (current price $614.23). Outliers above 5× or below 0.2× current price are excluded from the max but kept in the median. See methodology for the 6-method ensemble + 7 defenses.
Pillar breakdown
8 dimensions, each scored 0–100 against the universe
- QualityProfit margins & asset efficiency89Strong
- ValuePrice vs fundamentals28Poor
- GrowthRevenue & earnings trajectory86Strong
- MomentumRecent price strength53Decent
- HealthBalance sheet & solvency88Strong
- ProfitabilityROE, ROA, ROIC88Strong
- TechnicalTrend & volatility signals49Weak
- RiskVolatility & drawdown profile33Weak
Pillars not shown: Sentiment, ML (Phase 5+).
Raw fundamentals (SEC EDGAR)
| Metric | Value |
|---|---|
| Market cap | $1.57T |
| Revenue (TTM) | $214.96B |
| Net income (TTM) | $70.59B |
| Operating cash flow (TTM) | $124.00B |
| CapEx (TTM) | $75.75B |
| Free cash flow (TTM)CFO − CapEx | $48.25B |
| Total assets | $395.25B |
| Total liabilities | $151.57B |
| Stockholders' equity | $243.68B |
| Cash & equivalents | $23.43B |
| Shares outstanding | 2.56B |
| EPS (basic) | $10.57 |
| EPS (diluted) | $10.44 |
| P/E ratio (TTM) | 22.31 |
TTM = trailing twelve months. Balance sheet items are point-in-time (latest filing).
Data quality
- Latest filed date
- 2026-04-30
- Latest period end
- 2026-03-31
- Filing lag
- 16 days
- Missing metrics
- 3(gross_profit, inventory, short_term_debt)
Phase 3c — composite is the 8-pillar weighted score over quality, value, growth, momentum, health, profitability, technical, and risk. Sentiment + ML pillars land in Phases 5-6; until then their weight redistributes pro-rata. Fair price is the median of 6 valuation methods (Graham, P/E / P/B / EV-EBITDA multiples, RIM, DCF) with outliers above 5× current price excluded from the max. Risk-overlay flags annotate only — they suppress the entered-top-5 badge but do not modify the composite.